Quantcast

Latest BPH Stories

2011-09-27 18:04:37

NIH-funded study finds dietary supplement does not alleviate BPH Saw palmetto, a widely used herbal dietary supplement, does not reduce urinary problems associated with prostate enlargement any better than a placebo, according to research funded by the National Institutes of Health. The study was published Sept. 28 in the Journal of the American Medical Association. Prostate enlargement, also called benign prostatic hyperplasia (BPH), can cause frequent urination, a weak or intermittent...

2011-05-17 15:00:00

WASHINGTON, May 17, 2011 /PRNewswire/ -- New data presented today show that RAPAFLO(R) (silodosin) significantly reduced symptoms of moderate to severe chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). In the study presented at the annual meeting of the American Urological Association, RAPAFLO(R) also significantly improved urinary symptoms as well as quality of life. Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition characterized by persistent...

2011-05-08 00:05:47

"ËœNew Prostate Research', a TPRGlobal research news media service which gives men access to the latest prostate news, research and clinical trial information, has published two new research articles on prostate health. Sydney, Australia (PRWEB) May 07, 2011 "ËœNew Prostate Research', a TPRGlobal research news media service which gives men access to the latest prostate news, research and clinical trial information, has published two new research articles on prostate...

2011-05-04 13:50:00

MINNETONKA, Minn., May 4, 2011 /PRNewswire/ -- American Medical Systems® (AMS) (NASDAQ: AMMD), a leading provider of world-class devices and therapies for male and female pelvic health, today announced it has received clearance from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market and distribute its GreenLight HPS® laser therapy system for the treatment of Benign Prostatic Hyperplasia (BPH), or enlarged prostate, in Japan. As the...

2011-03-29 07:00:00

Prostatic Artery Embolization: Study Shows Symptom Improvement Comparable to "Gold Standard" Transurethral Resection of the Prostate--Without Surgical Risks of Sexual Dysfunction, Urinary Incontinence, Blood Loss, Retrograde Ejaculation CHICAGO, March 29, 2011 /PRNewswire-USNewswire/ -- A new interventional radiology treatment that blocks blood supply to men's enlarged prostate glands shows comparable clinical results to transurethral resection of the prostate (or TURP), considered the...

2011-03-22 08:10:00

PLEASANTON, Calif., March 22, 2011 /PRNewswire/ -- NeoTract, Inc. a medical device company focused on developing urology devices, today announced that the first U.S. patients have been enrolled in a multinational trial of its UroLift® System at Western Urological Clinic in Salt Lake City, Utah. The UroLift System is a minimally invasive approach to treating benign prostatic hyperplasia (BPH) that lifts prostate tissue out of the way so that it no longer blocks the...

2011-02-22 11:51:00

CHARLOTTESVILLE, Va., Feb. 22, 2011 /PRNewswire-USNewswire/ -- The Focused Ultrasound Surgery Foundation has released a special men's heath update in its February 2011 online newsletter. According to the update, tremendous progress is being made in developing new minimally-invasive and highly precise treatments for two conditions that afflict millions of men worldwide - prostate cancer and benign prostatic hyperplasia (BPH). By offering increased precision, the new treatments are...

2011-01-11 14:56:12

Researchers from Boston University School of Medicine (BUSM), in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors (5a-RIs), while improving urinary symptoms in patients with benign prostatic hyperplasia (BPH) and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction (ED), ejaculatory dysfunction and potential depression. These findings, which...

2010-10-22 14:05:48

A cholesterol-lowering drug reduced the enlarged prostates of hamsters to the same extent as a drug commonly used to treat benign prostatic hyperplasia (BPH), report researchers at Children's Hospital Boston and their colleagues in the October issue of the Journal of Urology. Together, the drugs worked even better. "We don't know the mechanism, but the results suggest to us that lowering cholesterol has the potential to reduce BPH in men," says senior author Keith Solomon, PhD, a biochemist,...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related